Can dexamethasone be used as an adjunct for analgesia in major skin grafting procedures performed under general anesthesia?

Yes, dexamethasone can and should be used as an adjunct for analgesia in major skin grafting procedures under general anaesthesia.

Intravenous dexamethasone 8 mg administered at induction of anaesthesia is recommended to reduce postoperative pain in adults undergoing major surgery, including skin grafting procedures 1. This recommendation is supported by expert panel guidelines with strong agreement (G2+).

Dosing and Administration

Adults

• Dose: 8 mg IV 1
• Timing: At induction of anaesthesia 1
• Route: Intravenous administration 2

Children

• Dose: 0.15 mg/kg (maximum 0.5 mg/kg) 1, 3
• Methylprednisolone 1 mg/kg is an alternative 3

Evidence for Analgesic Efficacy

The analgesic effects of dexamethasone are well-established across multiple surgical procedures:

• Pain reduction: Decreases pain scores at rest and with movement at ≤4 hours, 4-24 hours, and ≥24 hours postoperatively 4
• Opioid-sparing: Reduces 24-hour morphine consumption by approximately 6-20 mg 4, 5, 6
• Time to first analgesia: Increases time to first analgesic requirement by approximately 12-23 minutes 4, 6
• Mechanism: Anti-inflammatory, anti-hyperalgesic properties through suppression of the NLRP3/Caspase-1/IL-1β inflammatory pathway 7

Meta-analyses demonstrate that dexamethasone doses >0.1 mg/kg (approximately 8 mg in adults) are effective, with no additional benefit from higher doses 5. The effect size is modest but clinically meaningful when combined with other analgesics in a multimodal approach.

Integration into Multimodal Analgesia

Dexamethasone should be part of a comprehensive analgesic strategy for major skin grafting:

Basic analgesics (unless contraindicated):

• Paracetamol (acetaminophen) 1, 8, 9, 10
• NSAIDs (ibuprofen, diclofenac, ketorolac) 1, 8, 9, 10

Additional considerations for major procedures:

• Intravenous lidocaine: 1-2 mg/kg bolus followed by 1-2 mg/kg/h infusion for major surgery 1
• Ketamine: 0.5 mg/kg after induction for procedures with high pain risk, followed by 0.125-0.25 mg/kg/h 1
• Local anaesthetic infiltration: At surgical site 8
• Opioids: Reserved for rescue analgesia 8, 10

Safety Profile

Well-Tolerated Effects

Dexamethasone 8 mg as a single perioperative dose has an excellent safety profile 1, 6:

• No increased risk of:
  • Postoperative wound infection 9, 6, 11
  • Delayed wound healing at standard doses 6, 11
  • Bleeding when combined with NSAIDs 1

Important Caveats

Blood glucose elevation: Transient increase of approximately 0.39 mmol/L at 24 hours 6. This is generally clinically insignificant in non-diabetic patients but requires monitoring in diabetics 9.

Dose-dependent wound healing concerns: Animal studies suggest that higher doses (16 mg equivalent) may delay early wound healing more than moderate doses (8 mg) 7. Therefore, stick to 8 mg in adults rather than escalating to higher doses.

Contraindications to consider:

• Active systemic infection (relative contraindication)
• Poorly controlled diabetes (use with caution and monitor glucose)
• Haematological malignancies (risk of tumour lysis syndrome) 12

Additional Benefits

Beyond analgesia, dexamethasone provides:

• Anti-emetic effects: Reduces postoperative nausea and vomiting 1, 8, 10
• Enhanced recovery: May contribute to shorter PACU stays 6
• Improved quality of recovery: When part of ERAS protocols 9, 13

Practical Implementation

1. Administer 8 mg IV dexamethasone at induction of general anaesthesia
2. Combine with paracetamol and NSAIDs (started intraoperatively, continued postoperatively)
3. Consider regional techniques (local infiltration at graft sites) for additional analgesia
4. Reserve opioids for breakthrough pain
5. Monitor blood glucose in diabetic patients for 24 hours postoperatively

Do not combine NSAIDs with therapeutic anticoagulation (enoxaparin, rivaroxaban, warfarin) as this multiplies bleeding risk by 2.5-fold 1.